Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
News|Webcasts|September 16, 2024
Securing the Supply Chain for Small-Molecule APIs and Excipients & Minimal API
Webinar Date/Time: Fri, Sep 27, 2024 11:00 AM EDT
Run through key trends impacting small-molecule APIs and excipients, the importance of supply chain resilience, ways in which advanced manufacturing approaches can prove beneficial.
Register Free:
Event Overview:
In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about small-molecule APIs and excipients. During the discussion, expert(s) will run through key trends impacting small-molecule APIs and excipients, the importance of supply chain resilience, ways in which advanced manufacturing approaches can prove beneficial, and potential hurdles facing companies seeking to secure their small-molecule API and excipient supply chains.
This Episode of Drug Digest is sponsored by:
- Ligand
- Coatings Place
- Adare,
- Aprecia
- Biovectura
- LB Bohle
- Actylis
- Catalent
Key Learning Objectives:
- Understanding small-molecule API and excipient supply chains
- Discovering the importance of a resilient supply chain
- Learning about the potential benefits of advanced manufacturing approaches in securing the supply chain
- Learning about the potential hurdles that need to be overcome in securing the supply chain
Who Should Attend:
- CDMOs
- API manufacturers and suppliers
- Excipient manufacturers and suppliers
- Manufacturers
- Developers
Register Free:
Related to this article
Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains the benefits and challenges of the company’s just-in-time manufacturing solution.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Trending on Pharmaceutical Technology
1
Pimicotinib TGCT Approval Shows How Assessment Aid Supports Review
2
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
3
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
4
Our Biggest Takeaways From AAPS PharmSci 360
5